We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
N4 Pharma Plc | LSE:N4P | London | Ordinary Share | GB00BYW8QM32 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.80 | 0.75 | 0.85 | 0.80 | 0.80 | 0.80 | 198,696 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Drug & Proprietary Stores | 0 | -1.03M | -0.0057 | -1.40 | 1.45M |
Date | Subject | Author | Discuss |
---|---|---|---|
12/8/2020 23:57 | How Covid 19 pharmas have been performing during the last 6 month ( low v High ) AVCT 14p to 215p HEMO 1p to 15p NCYT 7p to 527p SNG 6p to 240p ODX 7p to 91p YGEN 7p to 24p N4P 2p to 15.75p -------------------- N4P 12.625p Market cap £19M, ( number of shares in issue 152M ) almost 1/3 of the shares being traded today 48.7M | master rsi | |
12/8/2020 22:58 | Are you mad??Its the progress they have made, and the potential if the last stage goes as planned.If your waiting for the day they say its successful and they have partnered with a big successful pharmaceutical company then your to late!! | greco600 | |
12/8/2020 22:40 | Hope no one takes notice here . If only one person listens to my advice then I’m happy. DYOR . Read all about the company and read all the rns . Even do an online covid course.Also remember n4p are not reliant on covid 19 . They were here long before and will be here long after. | charlie8888 | |
12/8/2020 22:34 | Not telling anyone to buy buy put bloe on your watch lists just in case news drops as somebody or more than one person as being buying about 60k cash worth almost every day for about a week now just seems strange for such a tiddler | fund1 | |
12/8/2020 22:31 | I feel sorry for all the new investors starting out who have listened to the tripe nobby and his crew or nobby and his aliases over the years have been spreading.He may just be an idiot to most but there are a few out there that will be thinking now he has cost me everything . Stopped me investing here only to go lose it elsewhere.Live n learn tho. There’s a nobby on all bbs .Just remember if the company was so bad there would be no one here to tell you. | charlie8888 | |
12/8/2020 22:30 | Complete irrational rise no real science and no commercial benefit as yet | turbotrader2 | |
12/8/2020 20:37 | Thought this looked nailed on to retrace tomorrow but now think the MMs held it back at the end. The v low Market cap stopped me from selling today Tomorrow morning could be interesting | michael boyle1 | |
12/8/2020 18:25 | As usual chirp is reliably dim. Do you seriously think a buyside firm will spike themselves on an RNS? As if portfolio managers tell their traders to chase penny shares about like some plonker with a few hundred quid in an HL account. Good grief give me strength.. I wonder if hugh will comment again?! | dplewis1 | |
12/8/2020 18:12 | Nah, there was oodles of stock to buy. | jibba jabber | |
12/8/2020 17:57 | This board is SO TROLL.Courtesy of tucky1961 on the (thank goodness) positive LSE board.One third of the company traded this afternoon. Quite astonishing. I think we're going to have another very busy day tomorrow and stock looks like it's getting harder to get hold of. A lot of those 200k+ trades will be going to people / institutions who will hold for the much bigger returns. | ch1rp | |
12/8/2020 17:45 | I think the mug punter express will be in town tomorrow to steam roller a bunch. | jibba jabber | |
12/8/2020 17:42 | Well guys you have all done very well today...but you got lucky. Nobody cares about transfecting a kidney cell line; that is really not difficult to do! All that is important is real cells in vivo and they are miles away from doing that. Mouse peripheral blood cells would have been much better because they are at least real cells and their excuse for not using them is absolutely pathetic. There is no shortage of mice so you can get as many cells as you want. I suspect it just didn't t work in 'real' cells but of course I have no direct evidence for that. The bottom line is that this RNS shows just a marginal step forward and certainly does not merit the rise. Of course that doesn't mean it won't go higher but be very wary.... | nobbygnome | |
12/8/2020 17:40 | Well that's a nice post lunch surprise. Very nice indeed. Where to next? Or more importantly, anyone wish to guess as to the timeline? | aaj2020 | |
12/8/2020 17:40 | Well guys you have all done very well today...but you got lucky. Nobody cares about transfecting a kidney cell line; that is really not difficult to do! All that is important is real cells in vivo and they are miles away from doing that. Mouse peripheral blood cells would have been much better because they are at least real cells and their excuse for not using them is absolutely pathetic. There is no shortage of mice so you can get as many cells as you want. I suspect it just didn't t work in 'real' cells but of course have no direct evidence for that. The bottom line is that this RNS shows just a marginal step forward and certainly does not merit the rise. Of course that doesn't mean it won't go higher but be very wary.... | nobbygnome | |
12/8/2020 17:33 | This wnt go up tomorrow | newtoaim | |
12/8/2020 17:29 | wheres lots of late buys | formula1187 | |
12/8/2020 17:20 | Lots of late buys. Going up:))) | ch1rp | |
12/8/2020 16:25 | LADIES AND GENTS LOOK AT DAILY CHART RSI AT 89. I TOLD YOU THIS EARLIER, HENCE LOADS OD DELAYED SELLS REPORTING. FURTHERMORE ANOTHER GRIMREAPER HAS APPEARED. BB8 IN BB8 WE TRUST | big brother8 | |
12/8/2020 16:07 | Level 2 13.25 v 14.25p 1 v 1 both sides CFED on the large spread it seems is the one in charge in this stock | master rsi | |
12/8/2020 16:02 | 30 minutes to go to the end of the day, so we could see the last push UP after so many retraces Level 2 13 v 13.50p 1 v 2 | master rsi |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions